Clinical Trial Update: Recombinant Fusion Protein Linking Coagulation Factor IX With Albumin (rIX-FP) in Chinese Subjects With Hemophilia B Previously Treated With FIX Therapy [Phase 3]

View source ↗

Summary

Phase 3 trial update of rIX-FP in Chinese patients with Hemophilia B previously treated with FIX therapy; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia B

Drugs mentioned

• rIX-FP (recombinant coagulation factor IX albumin fusion protein)

Snippet

Sponsor: CSL Behring | Conditions: Hemophilia B | Phase 3 | Status: COMPLETED